Atrioventricular block
Pro Research Analysisby 
Searched over 200M research papers for "atrioventricular block"
Consensus Meter
Understanding Atrioventricular Block: Mechanisms, Risk Factors, and Clinical Implications
Reflex Atrioventricular Block: Mechanisms and Clinical Relevance
Reflex atrioventricular block (AVB) is a condition that, although considered rare, is more common than previously thought. It can occur during vasovagal and carotid sinus reflexes and must be distinguished from paroxysmal AVB caused by ventricular conduction tissue disease. Low chronic adenosine levels combined with adenosine release can mimic reflex AVB. This condition is significant in clinical decision-making, particularly as an indication for heart pacing, considering the vasodepressor component of the reflex.
Risk Factors for Atrioventricular Block: Blood Pressure and Glucose Levels
Elevated blood pressure and blood glucose levels are significant modifiable risk factors for the development of AVB. A population-based cohort study involving 6146 individuals found that these factors could be associated with more than half of all AVB cases. Therefore, optimizing blood pressure and glucose control may be effective strategies to prevent conduction disease and the need for pacemaker implantation.
Inadvertent Atrioventricular Block During Radiofrequency Ablation
Inadvertent AVB is a known complication of radiofrequency catheter ablation, particularly in pediatric patients. The incidence of AVB during these procedures is influenced by the anatomical site of ablation and the experience of the institution performing the procedure. Anterior and midseptal accessory pathways and atrioventricular nodal reentry are particularly associated with higher risks of AVB.
Complete Atrioventricular Block in Myocardial Infarction
Complete atrioventricular block (CAVB) is a common and poor prognostic complication in patients with anterior ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI). The outcomes of CAVB in this context are not well understood, but it is recognized as a life-threatening arrhythmia requiring immediate attention.
First-Degree Atrioventricular Block: Heart Failure and Mortality
First-degree AVB, while often considered benign, is associated with an increased risk of atrial fibrillation, heart failure, and mortality, particularly in patients with heart failure and stable coronary artery disease. Cardiac pacing in these patients is linked to worse outcomes compared to those with normal atrioventricular conduction. Optimizing atrioventricular delay in patients with cardiac resynchronization therapy is crucial, although the best method for this remains unclear .
Animal Models for Studying Complete Atrioventricular Block
A rat model of chronic CAVB has been developed to reflect clinical indices of bradycardia and facilitate the study of disease progression and therapeutic strategies. This model shows structural remodeling and arrhythmogenicity similar to human CAVB, providing a valuable platform for testing new treatments.
Type 2 Diabetes Mellitus and Atrioventricular Block
Type 2 diabetes mellitus (T2DM) is significantly associated with a higher rate of third-degree AVB. A Danish nationwide study found that patients with T2DM had a higher incidence of third-degree AVB compared to matched controls, independent of other comorbidities and atrioventricular nodal blocking agents.
Paroxysmal Atrioventricular Block: Diagnosis and Risks
Paroxysmal AVB is characterized by sudden changes from normal atrioventricular conduction to complete heart block, leading to syncope and potential sudden cardiac death. This condition is often missed due to its unpredictability and the lack of clear evidence of conduction disease during normal conduction periods.
Atrioventricular Block as a Predictor of Atrial Fibrillation
AVB can serve as a predictor of clinical atrial fibrillation (AF), the most common cardiac arrhythmia. The relationship between AVB and AF is complex and controversial, but recognizing AVB as a risk factor for AF can aid in early diagnosis and management.
Conclusion
Atrioventricular block encompasses a range of conditions with varying mechanisms, risk factors, and clinical implications. Understanding these aspects is crucial for effective diagnosis, prevention, and treatment strategies, particularly in managing associated conditions like heart failure, myocardial infarction, and diabetes. Further research and optimized therapeutic approaches are essential to improve patient outcomes in AVB-related conditions.
Sources and full results
Most relevant research papers on this topic